List of works - Julie Fox

A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe

scientific article published in August 2022

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity

scientific article published on 29 October 2022

Analytical Advances in the Ex Vivo Challenge Efficacy Assay

scientific article published on 14 November 2016

Bone mineral density, kidney function and participant‐reported outcome measures in women who switch from tenofovir disoproxil emtricitabine and a nonnucleoside reverse transcriptase inhibitor to abacavir, lamivudine and dolutegravir

scientific article published on 5 December 2021

Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus

scientific article published on 13 January 2023

Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis

scientific article published on 13 June 2016

Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohort

scientific article published on 14 June 2021

CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype

scientific article published on 25 June 2019

ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants

scientific article published on 15 April 2022

Clinical outcomes of patients with and without HIV hospitalized with COVID-19 in England during the early stages of the pandemic: a matched retrospective multi-centre analysis (RECEDE-C19 study)

scientific article published in February 2022

Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trial

scientific article published on 30 October 2020

Comparison of Sexual Behavior and HIV Risk between Two HIV-1 Serodiscordant Couple Cohorts: The CHAVI 002 Study ⬇️

scientific article published on May 22, 2012

Could we, should we? Yes ⬇️

scientific article published on September 10, 2011

Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial

scientific article published on 17 October 2022

Epigenetic scars of CD8<sup>+</sup> T cell exhaustion persist after cure of chronic infection in humans

scientific article published on 26 July 2021

Follicle‐stimulating hormone in postmenopausal women living with HIV: a prevalence study

scientific article published on 17 November 2021

GSTM1 Copy Number and Kidney Disease in People With HIV

scientific article published in August 2022

Genetic Variants of Are Major Determinants of Kidney Failure in People of African Ancestry With HIV

scientific article published in April 2022

Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption

scientific article published in 2022

Low rates of p24 antigen detection using a fourth-generation point of care HIV test ⬇️

scientific article published on November 17, 2010

Menopausal status, age and management among women living with HIV in the UK

scientific article published on 26 July 2021

Missed opportunities for identifying primary HIV within genitourinary medical/HIV services ⬇️

scientific article published on August 1, 2012

Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa

scientific article published on 27 July 2022

No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approach

scientific article published in 2021

Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP)

scientific article published on 15 July 2021

Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue

scientific article published on 16 June 2022

Pre-exposure Prophylaxis for HIV Prevention: Why, What, Who and How

scientific article

Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom

scientific article published in August 2021

Preventing onward HIV transmission in routine HIV care: low levels of evaluation of risk behaviour in HIV-infected patients ⬇️

scientific article published on May 23, 2011

Proteomic Analysis of Mucosal and Systemic Responses to SARS-CoV-2 Antigen

scientific article published on 2 February 2023

Quantifying sexual exposure to HIV within an HIV-serodiscordant relationship: development of an algorithm ⬇️

scientific article published on May 15, 2011

Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK

scientific article published in April 2022

Renal Impairment Is Associated With Coronary Heart Disease in HIV-Positive Men ⬇️

scientific article published on November 1, 2012

Response to 'The use of tenofovir in patients with COVID-19'

scientific article published in September 2022

Self-start HIV postexposure prophylaxis (PEPSE), to reduce time to first dose and increase efficacy

scientific article published on 23 December 2022

Symptoms of post-traumatic stress and associations with sexual behaviour and PrEP preferences among young people in South Africa, Uganda and Zimbabwe

scientific article published on 16 May 2022

Tenofovir Disoproxil Fumarate Fails to Prevent HIV Acquisition or the Establishment of a Viral Reservoir: Two Case Reports

scientific article published on 9 January 2016

The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recen

scientific article published on 5 April 2022

The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern

scientific article published in October 2022

The epidemiology of kidney disease in people of African ancestry with HIV in the UK